succinylcholine has been researched along with cromolyn sodium in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Klinker, JF; Seifert, R | 1 |
2 other study(ies) available for succinylcholine and cromolyn sodium
Article | Year |
---|---|
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Morphine and muscle relaxants are receptor-independent G-protein activators and cromolyn is an inhibitor of stimulated G-protein activity.
Topics: Animals; Cattle; Cromolyn Sodium; Gallamine Triethiodide; GTP Phosphohydrolases; GTP-Binding Proteins; Heterotrimeric GTP-Binding Proteins; Morphine; Neuromuscular Depolarizing Agents; Neuromuscular Nondepolarizing Agents; Receptors, Drug; Succinylcholine; Transducin; Tubocurarine | 1997 |